Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke (EAST)
This study has been completed.
Study NCT00153946 Information provided by Combination Therapy for Acute Ischemic Stroke Study Group
First Received: September 8, 2005 Last Updated: May 12, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Additional conditions recognized in this trial
Cerebral Infarction
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Edaravone
Additional drug interventions recognized in this trial
Argatroban
Phenylmethylpyrazolone
More general drug interventions related to this trial
Anticoagulants
Antioxidants
Free Radical Scavengers
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Combination Therapy for Acute Ischemic Stroke Study Group
Japan Cardiovascular Research Foundation
Back to top of Main Content
